-+ 0.00%
-+ 0.00%
-+ 0.00%

Allarity Therapeutics Secures First Lab Services Contract With European Biotech Company

PUBT·10/30/2026 11:45:52
Listen to the news
Allarity Therapeutics Secures First Lab Services Contract With European Biotech Company
  • Allarity Therapeutics secured its first revenue-generating contract under its CLIA-certified laboratory services strategy with a European biotechnology company.
  • The agreement covers development and validation services for a precision oncology predictive device intended for US use.
  • Successful completion could lead to recurring commercial testing and CLIA-related service revenue.
  • Stenoparib remains its top development priority.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allarity Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610300745PRIMZONEFULLFEED1001280818) on October 30, 2026, and is solely responsible for the information contained therein.